A Phase II Clinical, Biological and Pharmacological Study of ZD1839 [gefitinib] in Patients With Advanced Colorectal Carcinoma Refractory to 5-Fluorouracil (5-FU) and Irinotecan Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2006
At a glance
- Drugs Gefitinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.